Objective: To determine the efficacy and safety of percutaneous ethanol injection (PEI) for the treatment of symptomatic cystic thyroid nodules. Patients and Methods: Retrospective analysis of patients with benign cystic thyroid nodules treated with PEI from February 1, 2000, through October 31, 2016. The main outcomes were efficacy, defined as symptom relief or reduction in nodule volume of 50% or more, and safety, defined as no or minor adverse events. Results: Twenty patients had PEI. Mean age at the time of PEI was 50 years, and 13 (65%) were women; all patients were euthyroid. Twelve patients (60%) had complex cystic thyroid nodules (>50% cystic component), with the rest being purely cystic. The median largest diameter of the thyroid cyst was 4.5 cm (interquartile range [IQR], 3.2-5.3 cm; range, 2.3-8.0 cm); the median volume pre-PEI was 19.6 mL (IQR, 10.4-48.5 mL; range, 2.8-118.1 mL). The median amount of cystic fluid drained before PEI was 13.5 mL (IQR, 6.8-32.3 mL), and the median amount of ethanol administered was 3 mL (IQR, 2-5 mL; range, 0.5-20 mL). After median follow-up of 2 years, 17 of 19 patients (89%) were asymptomatic. Of 10 patients with available imaging on follow-up, 7 (70%) had a 50% or greater reduction in nodule volume (median volume decrease, 75.64% [IQR,.99%]). Adverse effects occurred in 4 patients (20%) and were mild and temporary (slight pain, vagal reaction, and bleeding into the cyst). Conclusion: Percutaneous ethanol injection seems to be a safe and effective alternative to surgical resection for patients with purely or predominantly cystic thyroid nodules and compressive symptoms who decline surgery or are not good surgical candidates.
T hyroid nodules are common in clinical practice, and their incidence has increased with the use of highresolution ultrasonography. 1, 2 The management of thyroid nodules is complex as clinicians need to take into consideration patient features (age, comorbidities, and fitness for surgery), the presence or absence of compressive symptoms, the ultrasonography "imaging phenotype" and risk of malignancy, and patient preference. Ruling out malignancy is a priority in all patients, and imaging phenotype plus cytologic examination of fine-needle aspiration (FNA) biopsy are useful for this. 3 The American Thyroid Association (ATA) thyroid nodule sonographic patterns 4 consider pure cysts to be of negligible malignancy risk (benign), with a risk of malignancy of less than 1%; partially cystic nodules with no suspicious features to be of very low suspicion (<3% risk of malignancy); and partially cystic nodules with eccentric solid areas to be of low suspicion for malignancy (5%-10% risk). Once malignancy has been ruled out, further treatment usually depends on the presence of compressive symptoms because some patients with benign nodules may require surgery for symptomatic relief. 5, 6 In the case of patients with symptomatic thyroid cystic nodules, treatment options include simple nodule aspiration, minimally invasive techniques, or surgical resection. Aspiration can be performed, but recurrence rates are high, observed in approximately 60% to 90% of patients. 7 Surgical treatment is more definitive but may be associated with potential complications. 8 As a result, some patients are not interested in surgery, and others may sometimes be too sick due to existing comorbidities so that surgery is contraindicated. In such patients, minimally Percutaneous ethanol injection was first evaluated at the end of the 1980s, 10 and in the 1990s for the treatment of autonomous thyroid nodules as an alternative to surgery and radioiodine. 11 Percutaneous ethanol injection of benign thyroid cysts is performed under ultrasound guidance. Ethanol causes permanent tissue damage by cellular dehydration and protein denaturation, with subsequent necrosis, fibrosis, and thrombosis of small cyst wall blood vessels. 12, 13 The procedure is currently described as effective and safe for the treatment of benign thyroid cysts and complex nodules with a predominant cystic component. [14] [15] [16] In controlled studies, the remission rate after 1 to 3 PEI sessions is approximately 75% to 85%, compared with 7% to 38% after aspiration only or treatment with isotonic saline. 14, 16, 17 There is limited information on the use of PEI for the treatment of thyroid cysts in the American literature. Therefore, the aim of this study was to determine the efficacy and safety of this technique and to delineate the clinicopathologic outcomes of patients with thyroid cysts treated with PEI at Mayo Clinic's campus in Rochester, Minnesota.
PATIENTS AND METHODS

Study Design and Search Strategy
A retrospective review of medical records of all patients with a diagnosis of thyroid nodules treated with PEI at Mayo Clinic from February 1, 2000, through October 31, 2016, was performed. Eligible patients were identified by using the Mayo Clinic Life Sciences System Advanced Cohort Explorer search engine, which allows for rapid searching of the Mayo Clinic electronic record system, and the Radiology Information Management System.
Inclusion Criteria
Candidates for PEI included patients with purely or predominantly cystic (>50% cystic component) nodules, with a benign cytologic test result (in those with a solid component; for purely cystic nodules, a nondiagnostic result was acceptable) and with symptoms of compression or cosmetic concerns. Symptomatic nodules with persistent symptoms after simple drainage and symptotmatic nodules for which the primary intervention was PEI were included.
Efficacy and Safety
The efficacy of PEI was assessed by the degree of resolution of the patient's symptoms (based on documentation of symptoms on the medical record, no scale was used per the procedure's note report on the charts) and by the degree of volume reduction of the nodules during followup. A 50% or greater reduction in nodule volume from baseline was considered significant. Patients who had no follow-up at Mayo Clinic were contacted by telephone to evaluate for the presence of symptoms, thyroid nodule volume, and necessity of other therapies. If followup ultrasound imaging was performed at another institution, after proper authorization, the images (or radiology report, when images were not available) were submitted for review by our radiologist to assess objective response to therapy (R.A.L.).
Safety was assessed by review of the procedure note and postvisit follow-up. We specifically looked for bleeding, pain, hoarseness, or any other adverse effects described in the procedure note or during subsequent follow-up. We used the Society of Interventional Radiology classification system for complications by outcome. 18 The protocol was approved by Mayo Clinic Institutional Review Board.
PEI Procedure and Volume Calculations
Ethanol injection was performed under ultrasound guidance in all the patients using an 8-to 16-MHz probe with the General Electric Logiq E9 system (GE Healthcare) currently and the Acuson Sequioa system (Siemens) in the earlier years of the study and a 20-to 22-gauge needle. Four interventional radiologists performed the injections. Nodule volume and the percentage of volume reduction were calculated using the ellipsoid equation (length x width x depth x p/6) and the calculator available at the ATA website, and the percentage volume reduction was calculated using the following formula: [(initial volume e final volume) x 100%]/initial volume. 19 All the nodules were aspirated and drained as completely as possible immediately before PEI, then ethanol was injected and left in place for approximately 9 minutes and up to 25 minutes, and subsequently it was completely reaspirated.
Statistical Analyses
A descriptive summary analysis of patients' baseline characteristics was performed using JMP software, version 10.0.0 (SAS Institute Inc). Data are presented as frequencies (percentages) for the categorical variables and as mean AE SD or median (range [minimummaximum] or interquartile range [IQR]) as appropriate for the continuous variables; for normally distributed variables, means were preferred, and for nonnormal distribution, medians were used for data description.
RESULTS
Baseline Characteristics
Using the 2 search engines previously described, we identified 20 patients who received PEI for the treatment of thyroid cystic nodules at Mayo Clinic from February 1, 2000, through October 31, 2016. Most patients (n¼13; 65%) were women, with a mean AE SD age at the time of initial PEI of 50 AE 17.2 years. Family history of thyroid disease was present in 7 patients (35%). Most of these nodules were found by the patients themselves by palpation (n¼10; 50%), followed by incidental discovery on computed tomography in 4 (20%), physical examination by a physician in 4 (20%), and due to compressive symptoms in 2 (10%). Ultimately, all the patients developed symptoms (compressive/aesthetic), and thus the need for therapy. Patient preference was the most common reason for performing PEI in 18 of the patients (90%), instead of surgery or observation. In the other 2 patients, PEI was elected due to the presence of comorbidities or advanced age that rendered the patients poor surgical candidates (Table 1) .
Hormonal Evaluation at Baseline
All patients for whom serum thyrotropin levels were available were euthyroid at the time of PEI. The median thyrotropin level at the time of PEI was 1.34 mIU/L (IQR, 0.96-1.97 mIU/L), available for 18 patients (90%) ( Table 1 ). Free thyroxine concentration was available in 9 patients (45%) at the time of PEI, with a median value of 1.2 ng/dL (IQR, 1.07-1.55 ng/dL) (to convert to pmol/L, multiply by 12.871).
Cytologic Examination and Previous Aspirations
Most patients had 1 or more FNA attempts/ drainage before treatment with PEI. Previous FNA attempts were performed in 17 patients (85%), with a mean AE SD of 1.55 AE 0.99 FNAs per person (range, 0-3). A benign cytologic profile was confirmed in 16 patients (80%), and 4 patients (20%) with purely cystic nodules had nondiagnostic cytologic test results. Complex cyst is described as complex predominantly cystic thyroid nodules with 50% to 90% cystic component.
Thyroid Cystic Nodule Baseline Characteristics
Twelve patients (60%) had complex thyroid cysts (>50% but <90% cystic component) and 8 (40%) had pure thyroid cysts (>90% cystic). Additional thyroid nodules were present in 17 patients (85%) at the time of PEI. All other nodules had "low suspicion," "very low suspicion," or "benign" imaging phenotype at the time of PEI. The median largest diameter cyst size was 4.5 cm (IQR, 3.2-5.3 cm; range, 2.3-8.0 cm), and the median volume of the cystic nodules before PEI was 19.6 mL (IQR, 10.4-48.5 mL; range, 2.8-118.1 mL).
Treatment With PEI
The appearance of the aspirated cystic fluid before PEI was bloody to brownish in 15 patients (75%). The remaining patients' fluid was described as clear yellow. The median amount of cystic fluid drained before PEI was 13.5 mL (IQR, 6.8-32.3 mL; range, 2.1-70 mL). The median amount of ethanol administered in the first PEI was 3 mL (IQR, 2-5 mL; range, 0.5-20 mL). The median percentage of alcohol administered with respect to how much fluid was drained was 23% (IQR, 14%-40%). The median time that ethanol was left in the nodule was 9 minutes (IQR, 4.5-16.3 minutes; range, 1-25 minutes), followed by complete reaspiration of ethanol.
Safety
Adverse effects of PEI were minimal, with minor complications as per Society of Interventional Radiology classification, type A (no therapy needed and no consequence), with 1 patient (5%) reporting mild to moderate pain after the procedure with no need for analgesic treatment, 1 (5%) vasovagal reaction, and 2 (10%) bleeding into the cyst. Fortunately, all these adverse effects were transient and resolved spontaneously, and 16 patients (80%) reported no adverse effects. Although only 4 patients (20%) had local treatment with 1% lidocaine before the procedure, none of the procedures was stopped due to pain and no patient required admission to the hospital due to adverse events.
The PEI was performed as a single-day treatment in 18 patients (90%). The remaining 2 patients (10%) required 2 consecutive days of PEI therapy: in 1 patient the procedure was repeated due to initial large volume (63 mL) and in the other because of minimal change in volume after initial treatment (from 33 mL to 31 mL despite 12 mL of aspiration). The median cyst fluid drainage on the second day of PEI was 14.5 mL (range, 12-17 mL), and the median ethanol treatment volume was 2.7 mL (range, 2.4-3.0 mL). No symptoms or adverse events were reported after the second procedure.
One patient received a second PEI treatment at 3 months due to limited initial response (volume reduction after the first PEI of 13%). The amount of drained fluid during the second PEI was 20 mL and the appearance was bloody/brownish. He was treated with 15 mL of ethanol during this second intervention. The patient experienced mild transient pain as an adverse effect. Eleven months after the second PEI procedure, nodule volume had decreased an additional 38.6%. Efficacy Symptom Control. All 20 patients (100%) reported improvement in compressive/aesthetic symptoms the day after the PEI procedure. Clinical follow-up information was available in 19 patients (95%), and 1 patient was lost to follow-up. Median clinical follow-up was 2 years (IQR, 1-4 years; range, 0.6-13 years).
At last follow-up, 17 of 19 patients (89%) were asymptomatic. In 3 patients (16%), there was either no change, minimal transient improvement, or recurrence. Two of these patients underwent surgery, and the other one (with a complex nodule) was treated with radiofrequency ablation. No follow-up information is available on this patient after radiofrequency ablation. Of the 2 surgical patients, 1 had a lobectomy due to cyst recurrence with benign histopathologic examination results (no follow-up ultrasound available before surgery) and the other had a total thyroidectomy due to a multinodular goiter, and a 1.3-cm papillary thyroid cancer was later diagnosed in the contralateral lobe; the cystic (index) lesion on pathologic examination was a 3.2-cm noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
Volume Reduction. A repeated neck ultrasound was available in 10 patients (50%). Median follow-up was 15.5 months (IQR, 7-58.25 months; range, 3-96 months). The median final volume on last follow-up ultrasound was 8.63 mL (IQR, 0.47-18.3 mL; range, 0.29-46 mL), and median volume reduction was 76% (IQR, 41%-92%; range, 0%-97%).
Specific detailed information regarding these 10 patients is summarized in Table 2 . Figures 1 and 2 show examples of thyroid cystic response to therapy with PEI with 50% or greater volume reduction.
DISCUSSION
Patients with symptomatic benign thyroid nodules are common. In the case of patients with cystic or predominantly cystic nodules that are symptomatic, treatment options include aspiration (associated with a high rate of recurrence), surgery, and PEI. Besides the possible local complications of surgery, many patients develop hypothyroidism after lobectomy as an unintended consequence. Weighing risks and benefits, current guidelines 4, 20 and other experts in the field 12,21-27 suggest that PEI may be first-line therapy for these patients. The present data prove once again that this procedure, when performed by experienced operators, is safe and effective in the treatment of these lesions, with a success rate of 70% as defined by a reduction of volume size from baseline of 50% or more and with symptom relief in most patients (17 of 19; 89%) for whom follow-up ultrasound findings or clinical information was available.
Most of the original studies 17, 25, 26, [28] [29] [30] [31] [32] that assessed the efficacy and safety of PEI were conducted in Europe (Italy) and Asia between 1992 and 2002, reporting success rates for this procedure of 64% to 95%; success was defined as almost complete disappearance of the cyst or marked reduction in volume (>50%) associated with symptom control. The number of patients in each of these studies ranged from 10 17 to 98 30 ; the latter study is probably the one with the largest follow-up, for up to 10 years. Only 1 of these initial studies 17 was a randomized controlled trial that compared aspiration and saline flushing with PEI, reporting a success rate of 80% for PEI and including 10 patients. The present success rate is consistent with these early reports because 70% of patients (n¼7) with available ultrasound on followup had a 50% or greater reduction in nodule volume after PEI and, most importantly, approximately 90% of the patients were asymptomatic at median follow-up of 2 years. At last follow-up had increased by 52% and was treated surgically.
c Seven of 10 patients (70%) had a decrease in volume size from baseline of 50% or greater.
In 2003, a Danish randomized controlled trial was published, 14 with 33 patients randomized to receive PEI and 33 to receive placebo saline solution; 82% of patients treated with PEI were cured at 6-month follow-up (cyst volume 1 mL) vs 48% of those treated with saline. The number of previous aspirations (P<.005) and baseline cyst volume (P<.005) had influence on the outcome, with the chance of success decreasing with the number of previous aspirations and with increasing cyst volume. Seven patients (21%) treated with PEI had moderate to severe pain lasting a median of 5 minutes, and 1 had transient dysphonia. They concluded that flushing with ethanol is an effective alternative to surgery for thyroid cysts that recur despite repeated aspiration.
An Italian randomized controlled trial in 2004 16 in which 143 patients underwent cyst drainage plus PEI and 138 patients had only simple cyst drainage found that after 1 year the PEI group had a median volume reduction of 86% compared with 7.3% for the aspiration only group (P<.001). Compressive and cosmetic symptoms resolved in 75% and 80% of patients treated with PEI vs 24% and 37% of patients treated with aspiration only, respectively (P<.001). A 2009 Indian study 13 of 15 patients treated with PEI reported a response rate of 87%, with complete disappearance of the cyst in 27% of patients and a significant reduction in cyst volume (of !50%) in 60% of patients. 33 Most recently, a 2016 Brazilian study 15 treated 36 patients with PEI and compared them with 13 patients who refused PEI and were followed clinically or with treatments other than surgery; in the PEI group, the mean reduction in volume at 30 days was 68%, and at long-term follow-up (mean, 14 months) the volume had decreased by 78% from baseline, whereas there was no significant change in mean AE SD volume in the control group (5.8 AE 3.4 cm 3 at baseline and 6.2 AE 3 cm 3 after 26 months). The present study results are consistent with these reports, as we had a reduction in volume of 76% on follow-up and overall clinical improvement in 89% of patients.
In a recently published meta-analysis, 34 of the 31 included studies, only 8 evaluated the role of PEI in benign thyroid nodules. They were all single-institution studies conducted in European or Asian countries; of these studies, only 4 performed PEI specifically for thyroid cysts. Compared with simple cyst aspiration, PEI was associated with a significant nodule volume reduction in 83% compared with 44% of participants after 1 to 24 months of follow-up (relative risk, 1.83 [95% CI, 1.32-2.54]). Improvements in compressive symptoms after 6 to 12 months of follow-up were seen in 78% of participants receiving PEI vs 38% of those in comparator groups. Adverse effects were few and transient: mild to moderate pain, local burning sensation, and transient dysphonia. In the present study, we also found that PEI seems to be a safe procedure, with few and temporary adverse effects.
In terms of risk of recurrence, a study from South Korea 35 reported a recurrence rate of 38% (41 of 107) after PEI, with multivariate analysis finding that initial volume (>20 mL; P<.04) and vascularity (grade >1; P<.049) were independent predictors of volume reduction at last follow-up.
During ethanol administration under ultrasound guidance, the partially refilled cyst content appears as hyperechoic microbubbles swirling about, sometimes with a small amount of hemorrhagic fluid. On follow-up these PEI-treated nodules might show some imaging phenotype characteristics suggestive of malignancy, as assessed by a Korean study 36 in which 40 thyroid cystic nodules were analyzed and followed for a median of 18.2 months; on follow-up, 28 nodules had marked hypoechogenicity, 31 had no vascularity, 6 had microcalcifications, and 7 showed speculated margins, concluding that during long-term follow-up there is a high incidence of findings that are usually associated with malignancy and that recognizing this is important to avoid unnecessary FNA of these PEI-treated nodules.
The definition of success varies in many of the studies discussed so far. Although most studies indicate that a reduction of 50% or greater of the nodule volume is considered a successful treatment, another measure of success, and probably a more important one, is the resolution of compressive or cosmetic symptoms (triggering further treatments) because these symptoms are the actual indication for treatment in this otherwise benign entity. Most patients in the present study (89%) experienced resolution of symptoms at last follow-up. Therefore, PEI seems to be effective in controlling symptoms without the need for surgical intervention.
True standardization of the method of PEI is not quite clear or straightforward. It seems that total or partial aspiration before ablation is a rule in all patients, but the amount of ethanol injected with respect to how much was drained has varied in the available literature, ranging from 10% to 100% of the drained fluid. [14] [15] [16] 22, 29, 32, 33, 37 In some studies, the ethanol injected into the cyst is left in place briefly (usually 2-10 minutes) before reaspiration, 14, 31, 35 whereas some other studies have left the injected ethanol in the cyst without mention of reaspiration. 12, 26, 30, 37, 38 At Mayo Clinic, ethanol is left in the cyst for a median of approximately 8 to 10 minutes and then is reaspirated.
In the present study the amount of ethanol administered for the first PEI was 23% of the drained fluid (IQR, 14%-40%; range, 4%-100%) for the whole cohort, so in the range of the reported literature.
Current American Association of Clinical Endocrinologists/Associazione Medici Endocrinologi/European Thyroid Association guidelines 39 indicate that ultrasound-guided PEI is an effective treatment modality for benign thyroid cysts and complex nodules with a large cystic component. Percutaneous ethanol injection should not be performed in solitary solid nodules, whether hyperfunctioning or not, or in multinodular goiters. The 2016 ATA guidelines 4 comment that aspiration with or without ethanol ablation may be considered as a therapeutic intervention if a cyst is large and symptomatic.
Strengths and Limitations
The main limitations of this study are related to its retrospective nature, which limits our ability to objectively assess some outcomes; the small sample size and median follow-up of 2 years; and the fact that repeated imaging was available in only half of the study population (which might be expected in the absence of symptoms). Despite these limitations, this is, to our knowledge, the first report of the safety and efficacy of PEI in the United States, and the data seem to be consistent with previous reports from Europe, Asia, and South America. [14] [15] [16] [17] 30, 38 Clinical Implications These study results indicate that PEI is an effective and safe alternative to conventional surgery in patients with large, benign, symptomatic cystic nodules, who would prefer other alternatives to surgery or are otherwise poor surgical candidates. We hope that this first attempt to characterize a US population treated with PEI might help to overcome the delay in the applicability of this minimally invasive technique in the treatment of symptomatic thyroid cysts in the United States, a technique that has otherwise been used by our international colleagues for a considerable time. In the era of personalized medicine and shared decision making, the availability of alternative, less invasive procedures for the treatment of otherwise benign thyroid disease seems most appropriate. As such, the results of this study can be used to counsel patients interested in alternatives to surgery.
CONCLUSION
These study results indicate that benign thyroid cysts that recur after aspiration can be safely and effectively treated with PEI in patients who prefer this modality of treatment or in whom surgery is contraindicated. Although this type of treatment has been reported to be beneficial in other parts of the world, the lack of published studies regarding this procedure in the United States may be related to lack of experience in our centers. This is the first study to demonstrate its safety and efficacy in a tertiary center in the United States.
Abbreviations and Acronyms: ATA = American Thyroid Association; FNA = fine-needle aspiration; IQR = interquartile range; PEI = percutaneous ethanol injection
